New bioresorbable filaments for scaffolds intending local sodium alendronate release

Abstract

Scaffolds with osteoconductivity, biocompatibility and good mechanical properties are promising for local drug release of sodium alendronate (ALN), a first-choice drug for treatment of bone tissue diseases, with low bioavailability. The viability to manufacture poly (L-lactic acid) (PLLA)/poly (methyl methacrylate) (PMMA) filaments containing ALN in different proportions, through extrusion, followed by scaffolds using 3D printing by fusion deposition modelling (FDM) and to investigate the influence of processes in mixtures drove this study. Differential scanning calorimetry (DSC), spectroscopy in the infrared region with Fourier transform (FTIR/ATR), and X-ray diffractometry (XRD) analysis indicated that PMMA decelerates crystallinity and confers malleability to PLLA/ALN mixture, besides its good processability and miscibility with PLLA and no relevant changes in physicochemical properties of components. Field emission scanning electron microscopy (SEM/FEG) showed good interfacial compatibility between PLLA/PMMA and homogeneously dispersed drug crystals in matrix. PLLA-PMMA-ALN scaffolds were manufactured by accurate with interesting properties for bone tissue engineering.